Home / RGIN : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does RGIN make money? Does RGIN have pricing power? What's the Earnings Whisper? Will RGIN profit more as the business scales? What is RGIN's management track record? Is RGIN's current price justified?

Regenicin, Inc.

$0 -$0.00 (-66.67%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0 - $0

Year Range

$0$0.75

Market Cap

15.35K

AVG Volume

92.5K

Trailing/Forward PE

-0.02/-

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD) · TTM

RGIN Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
23 Q2	0
23 Q1	0
22 Q4	0
22 Q3	0
22 Q2	0
22 Q1	0
21 Q4	0
21 Q3	0
21 Q2	0
21 Q1	0

Net Income (USD) · TTM

RGIN Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
23 Q2	-968.09K
23 Q1	-800.65K
22 Q4	-677.14K
22 Q3	-599.08K
22 Q2	-600.42K
22 Q1	-664.72K
21 Q4	-670.6K
21 Q3	-559.65K
21 Q2	-566.14K
21 Q1	-521.84K

Operating Income (USD) · TTM

RGIN Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
23 Q2	-894.87K
23 Q1	-725.03K
22 Q4	-604.41K
22 Q3	-768.25K
22 Q2	-770.81K
22 Q1	-838.55K
21 Q4	-842.36K
21 Q3	-678.6K
21 Q2	-685.1K
21 Q1	-622.36K

EBITDA (USD) · TTM

RGIN EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
23 Q2	-818.83K
23 Q1	-648.29K
22 Q4	-580.05K
22 Q3	-762.5K
22 Q2	-766.03K
22 Q1	-834.07K
21 Q4	-840.66K
21 Q3	-524.64K
21 Q2	-531.39K
21 Q1	-470.35K

Cash Flows (USD) · TTM

RGIN Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
23 Q2	-700.22K
23 Q1	-378.45K
22 Q4	-27.29K
22 Q3	-28.87K
22 Q2	-28.24K
22 Q1	-23.14K
21 Q4	-23.7K
21 Q3	-48.28K
21 Q2	-38.91K
21 Q1	-53.65K

EPS (USD) · TTM

RGIN EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
23 Q2	-0.01
23 Q1	-0.01
22 Q4	-0
22 Q3	-0
22 Q2	-0
22 Q1	-0
21 Q4	-0
21 Q3	-0
21 Q2	-0
21 Q1	-0

Expenses (USD) · TTM

RGIN Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
23 Q2	894.59K
23 Q1	722.27K
22 Q4	601.18K
22 Q3	558.52K
22 Q2	561.36K
22 Q1	631.58K
21 Q4	635.86K
21 Q3	678.6K
21 Q2	685.1K
21 Q1	622.22K

Shares Outstanding · TTM

RGIN Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
23 Q2	0
23 Q1	0
22 Q4	0
22 Q3	0
22 Q2	0
22 Q1	0
21 Q4	0
21 Q3	0
21 Q2	0
21 Q1	0

Employee Count

RGIN Employee Count by quarter
Period	Employee Count
2022	3
2021	3
2020	3
2019	3
2018	3
2017	3
2016	3
2015	3
2014	3
2013	4

PE Ratio

RGIN PE Ratio by quarter
Period	PE Ratio
Feb 16	12.63
Feb 16	12
Jan 16	12
Jan 16	11.94
Jan 16	12.32
Jan 16	0.49
Dec 15	0.53
Dec 15	0.53
Dec 15	0.53
Dec 15	0.41
Dec 15	0.47
Nov 15	0.6
Nov 15	0.6
Nov 15	0.49
Nov 15	0.6
Oct 15	0.6
Oct 15	0.6
Oct 15	0.44
Oct 15	0.52
Oct 15	0.6
Sep 15	0.55
Sep 15	0.63
Sep 15	0.66
Sep 15	0.51
Aug 15	0.73
Aug 15	0.55
Aug 15	0.67
Aug 15	0.63
Jul 15	0.55
Jul 15	0.61
Jul 15	0.79
Jul 15	0.61
Jul 15	0.57
Jun 15	0.56
Jun 15	0.47
Jun 15	0.48
Jun 15	0.37
May 15	0.59
May 15	0.59
May 15	0.73
May 15	0.49
May 15	0.5
Apr 15	0.53
Apr 15	0.51
Apr 15	0.56
Apr 15	0.63
Mar 15	0.61
Mar 15	0.73
Mar 15	0.7
Mar 15	0.93
Feb 15	0.96
Feb 15	1.93
Feb 15	1.3
Feb 15	1.37
Jan 15	1.24
Jan 15	1.62
Jan 15	1.43

Free Cash Flow Yield

RGIN Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-4562.19%
Sep 26	-4562.19%
Aug 26	-4562.19%
Aug 26	-4562.19%
Aug 26	-4562.19%
Aug 26	-4562.19%
Jul 26	-4562.19%
Jul 26	-4562.19%
Jul 26	-4562.19%
Jul 26	-4562.19%
Jul 26	-4562.19%
Jun 26	-4562.19%
Jun 26	-4562.19%
Jun 26	-4562.19%
Jun 26	-4562.19%
May 26	-4562.19%
May 26	-4562.19%
May 26	-4562.19%
May 26	-4562.19%
May 26	-4562.19%
Apr 26	-4562.19%
Apr 26	-4562.19%
Apr 26	-4562.19%
Apr 26	-4562.19%
Mar 26	-4562.19%
Mar 26	-4562.19%
Mar 26	-4562.19%
Mar 26	-4562.19%
Feb 26	-4562.19%
Feb 26	-4562.19%
Feb 26	-4562.19%
Feb 26	-4562.19%
Jan 26	-4562.19%
Jan 26	-1520.73%
Jan 26	-1520.73%
Jan 26	-1520.73%
Jan 26	-1520.73%
Dec 25	-912.44%
Dec 25	-2281.1%
Dec 25	-4562.19%
Dec 25	-4562.19%
Nov 25	-4562.19%
Nov 25	-4562.19%
Nov 25	-4562.19%
Nov 25	-4562.19%
Oct 25	-4562.19%
Oct 25	-4562.19%
Oct 25	-4562.19%
Oct 25	-4562.19%
Oct 25	-4562.19%
Sep 25	-4562.19%
Sep 25	-4562.19%
Sep 25	-4562.19%
Sep 25	-4562.19%
Aug 25	-4562.19%
Aug 25	-4562.19%
Aug 25	-4562.19%
Aug 25	-4562.19%
Aug 25	-4562.19%
Jul 25	-4562.19%
Jul 25	-4562.19%
Jul 25	-4562.19%
Jul 25	-4562.19%
Jun 25	-4562.19%
Jun 25	-4562.19%
Jun 25	-4562.19%
Jun 25	-4562.19%
May 25	-4562.19%
May 25	-4562.19%
May 25	-4562.19%
May 25	-4562.19%
May 25	-4562.19%
Apr 25	-4562.19%
Apr 25	-4562.19%
Apr 25	-4562.19%
Apr 25	-4562.19%
Mar 25	-4562.19%
Mar 25	-4562.19%
Mar 25	-4562.19%
Mar 25	-4562.19%
Feb 25	-4562.19%
Feb 25	-4562.19%
Feb 25	-4562.19%
Feb 25	-4562.19%
Jan 25	-4562.19%
Jan 25	-4562.19%
Jan 25	-4562.19%
Jan 25	-4562.19%
Jan 25	-4562.19%
Dec 24	-4562.19%
Dec 24	-4562.19%
Dec 24	-4562.19%
Dec 24	-4562.19%
Nov 24	-456219.11%
Nov 24	-4562.19%
Nov 24	-4562.19%
May 24	-4562.19%
May 24	-4562.19%
Apr 24	-4562.19%
Apr 24	-4562.19%

Price to Sales

RGIN Price to Sales by quarter
Period	Price to Sales
Jan 14	256.37
Jan 14	244.87
Dec 13	282.89
Dec 13	380.13
Dec 13	380.13
Dec 13	387.2
Nov 13	222.77
Nov 13	229.84
Nov 13	178.57
Nov 13	198.9
Nov 13	159.12
Oct 13	221
Oct 13	296.15
Oct 13	238.68
Oct 13	213.05
Sep 13	177.69
Sep 13	234.26
Sep 13	265.21
Sep 13	282.89
Aug 13	120.23
Aug 13	243.1

EV/EBITDA

RGIN EV/EBITDA by quarter
Period	EV/EBITDA
Feb 16	0.57
Feb 16	0.52
Jan 16	0.52
Jan 16	0.52
Jan 16	0.55
Jan 16	0.47
Dec 15	0.53
Dec 15	0.54
Dec 15	0.54
Dec 15	0.33
Dec 15	0.43
Nov 15	0.66
Nov 15	0.66
Nov 15	0.47
Nov 15	0.66
Oct 15	0.66
Oct 15	0.66
Oct 15	0.38
Oct 15	0.51
Oct 15	0.66
Sep 15	0.58
Sep 15	0.7
Sep 15	0.74
Sep 15	0.5
Aug 15	0.87
Aug 15	0.57
Aug 15	0.77
Aug 15	0.52
Jul 15	0.39
Jul 15	0.49
Jul 15	0.77
Jul 15	0.49
Jul 15	0.42
Jun 15	0.39
Jun 15	0.25
Jun 15	0.27
Jun 15	0.1
May 15	0.44
May 15	0.45
May 15	0.94
May 15	0.66
May 15	0.68
Apr 15	0.71
Apr 15	0.69
Apr 15	0.75
Apr 15	0.83
Mar 15	0.8
Mar 15	0.94
Mar 15	0.9
Mar 15	1.17
Feb 15	1.21

Price to Book

RGIN Price to Book by quarter
Period	Price to Book
Jan 16	3.65
Dec 15	3.91
Dec 15	3.93
Dec 15	3.93
Dec 15	3.03
Dec 15	3.46
Nov 15	4.47
Nov 15	4.49
Nov 15	3.65
Nov 15	4.49
Oct 15	4.49
Oct 15	4.49
Oct 15	3.25
Oct 15	3.83
Oct 15	4.47
Sep 15	4.11
Sep 15	4.67
Sep 15	4.86
Sep 15	3.76
Aug 15	5.4
Aug 15	4.08
Aug 15	4.97
Aug 15	3.21
Jul 15	2.79
Jul 15	3.1
Jul 15	3.98
Jul 15	3.1
Jul 15	2.89
Jun 15	2.81
Jun 15	2.37
Jun 15	2.43
Jun 15	1.89
May 15	2.96
May 15	2.97
May 15	4.64
May 15	3.1
May 15	3.21
Apr 15	3.38
Apr 15	3.27
Apr 15	3.59
Apr 15	4.03
Mar 15	3.9
Mar 15	4.66
Mar 15	4.43
Mar 15	5.91
Feb 15	6.1

No video analysis for this stock yet. Request one from our team.

News: RGIN

defenseworld.net · 24 Aug 2026

Monopar Therapeutics (NASDAQ:MNPR) and Regenicin (OTCMKTS:RGIN) Head-To-Head Contrast

Regenicin (OTCMKTS:RGIN - Get Free Report) and Monopar Therapeutics (NASDAQ: MNPR - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Profitability This table compares Regenicin and Monopar Therapeutics' net

AI Analysis

Regenicin, Inc.

Video analysis: RGIN

News: RGIN

Monopar Therapeutics (NASDAQ:MNPR) and Regenicin (OTCMKTS:RGIN) Head-To-Head Contrast

Similar companies